EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer

Mohammed H Abu-Alghayth, Farhan R Khan, Tareg M Belali, Adil Abalkhail, Khalid Alshaghdali, Somia A Nassar, Nasser Eissa Almoammar, Hassan H Almasoudi, Khater Balatone G Hessien, Munirah Saad Aldossari, Abdulkarim S Binshaya

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155180 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Mohammed H Abu-Alghayth und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Bisha, P.O. Box 255, 67714, Saudi Arabia. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 149 Literaturangaben. Gefördert von: University of Bisha, Prince Sattam bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer persists as a major problem for the world's healthcare, thus it is essential to fully understand the complex molecular processes that cause its growth and development. ncRNAs had been discovered to serve critical roles in a variety of cellular functions, including the regulation of signalling pathways. Within different pathways, the AKT/PI3K/mTOR signalling cascade has received a lot of interest because of its role in cancer. A complex interaction between ncRNAs, notably miRNAs, lncRNAs, and circRNAs, and the AKT/PI3K/mTOR signalling pathway exerts both oncogenic and tumor-suppressive activities by targeting critical components of the pathway directly or indirectly. Through miRNA-mediated post-transcriptional regulation, lncRNA-guided chromatin remodelling, and circRNA sequestration, ncRNAs modulate the activity of PI3K, AKT, and mTOR, influencing cell proliferation, survival, and metastasis. Furthermore, ncRNAs can serve as promising biomarkers for breast cancer prognosis, diagnosis, and treatment response, as their dysregulation is commonly observed in breast cancer patients. Harnessing the potential of ncRNAs as therapeutic targets or tools for restoring pathway homeostasis holds promise for innovative treatment strategies in breast cancer. Understanding the intricate regulatory networks orchestrated by ncRNAs in this context may pave the way for novel diagnostic approaches, therapeutic interventions, and a deeper comprehension of breast cancer's molecular landscape, ultimately improving patient outcomes. This abstract underscores the emerging significance of ncRNAs in the AKT/PI3K/mTOR signaling pathway in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsRNA, Long NoncodingFemaleHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, UntranslatedSignal TransductionTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

And the AKT/ PI3K/mTOR signaling pathwayBreast cancerCancerCircular RNAsLong noncoding RNAsMicroRNAs

Substanzen

MicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Long NoncodingRNA, UntranslatedTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Bisha, P.O. Box 255, 67714, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al- Quwayiyah, Shaqra University, Riyadh, Saudi Arabia.
  • Department of Public Health, College of Applied Medical Sciences, Qassim University, Qassim, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, P.O Box 2440, Saudi Arabia.
  • Department of Medical Laboratory Science, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia; Department of Parasitology & Animal Diseases, National Research Centre…
  • Department of Medical Laboratory Science, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.

Förderung

  • University of Bisha
  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Abu-Alghayth, M. H., Khan, F. R., Belali, T. M., Abalkhail, A., Alshaghdali, K., Nassar, S. A., Almoammar, N. E., Almasoudi, H. H., Hessien, K. B. G., Aldossari, M. S., & Binshaya, A. S. (2024). The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155180

Vancouver

Abu-Alghayth MH, Khan FR, Belali TM, Abalkhail A, Alshaghdali K, Nassar SA, et al. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155180

BibTeX
@article{AbuAlghayth2024,
  author = {Abu-Alghayth, Mohammed H and Khan, Farhan R and Belali, Tareg M and Abalkhail, Adil and Alshaghdali, Khalid and Nassar, Somia A and Almoammar, Nasser Eissa and Almasoudi, Hassan H and Hessien, Khater Balatone G and Aldossari, Munirah Saad and Binshaya, Abdulkarim S},
  title = {The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155180}
}
Kostenlos starten →